Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
22 July 2021 | Story Ruan Bruwer | Photo Roger Sedres
Can Wayde van Niekerk repeat his amazing feat from the 2016 Olympics – now five years later – at the next Games?
It is a year later, but the Tokyo 2020 Olympics finally started on Friday, 23 July 2021. In team South Africa, a couple of the athletes and management, many of them medal contenders, call themselves Kovsies.

From 1 August, the progress of the country’s golden boy, Wayde van Niekerk, will be closely followed when he tries to hold on to the title as Olympic 400 m champion – he is still the world record holder (set at the 2016 Games). The final of the 400 m is scheduled for 5 August.

One of only five female athletes in the South African team, Gerda Steyn will compete in the marathon on 7 August. This is her first time at the Olympics. 

She is in red-hot form. In April, she broke a 25-year record in Italy when she ran the fastest-ever marathon by a South African woman, finishing in 2:25:28. She is the defending Comrades and Two Oceans champ.

Protea hockey player, Nicole Erasmus, will become a fourth-generation Olympic contender in her family. Her mother, Lynne Walraven (née Tasker) was a Zimbabwean swimmer, her great-uncle, Anthony Tasker, was a member of the South African rowing team, and her great-great-uncle, Frank Rushton, was a South African hurdles athlete. 

From 26 to 28 July, the South African sevens rugby team, with former Shimlas Chris Dry as a team member and Neil Powell as head coach, will aim to improve on their bronze medal achieved in 2016. Powell was also the head coach at the time, and another former Kovsie, Philip Snyman, captained the Blitzboks.

Kate Murray (formerly Roberts), head coach and high-performance manager of Triathlon South Africa, will act as the SA triathlon coach. She is a double Olympic participant, having raced for South Africa at the 2008 and 2012 Olympic Games.

 


News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept